New Interferon Formulations Promise to Eliminate Injections in Multiple Sclerosis Treatment
January 12, 2009 03:01 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - January 12, 2009) - Nerveda Inc. and Aegis Therapeutics LLC today
announced preclinical results from their joint collaboration aimed at
developing non-injectable...
Preclinical Study Presented at the International Congress of Endocrinology Shows Intravail(R) Drug Delivery Technology Provides Unmatched Non-Invasive Delivery of an Anti-Obesity Peptide
November 12, 2008 15:20 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - November 12, 2008) - Aegis Therapeutics LLC announced today that
preclinical data was presented at the 2008 International Congress of
Endocrinology in Rio de Janeiro,...
Aegis Therapeutics Awarded Patent for Its ProTek(R) Room Temperature Stable Human Growth Hormone Formulations Suitable for Metered Nasal Spray Delivery
September 16, 2008 04:00 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - September 16, 2008) - Aegis Therapeutics LLC announced today that
it has been awarded U.S. Patent 7,425,542, titled "Stabilizing
alkylglycoside compositions and methods...
Aegis Therapeutics to Present at the "4th Modern Drug Discovery & Development Summit" in San Diego, CA, October 15-17, 2008
September 08, 2008 04:00 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - September 8, 2008) - Aegis Therapeutics, a drug delivery
technology licensing company and leader in transmucosal drug delivery, will
present a talk entitled:...
Aegis Therapeutics to Present at the "13th Annual Drug Delivery Summit" in New Brunswick, NJ, September 22-23, 2008
August 21, 2008 04:00 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - August 21, 2008) - Aegis Therapeutics, a drug delivery
technology licensing company and leader in transmucosal drug delivery, will
present a talk entitled: "New...
Aegis Therapeutics to Present at the "C21 BioVentures Conference" in Monterey California in May 2007
April 04, 2007 10:00 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA -- (MARKET WIRE) -- April 4, 2007 -- Aegis Therapeutics, a drug delivery
technology licensing company and leader in transmucosal drug delivery, will
present its recently formed Cedar...
Aegis Therapeutics to Present Intravail(R) and ProTek(R) Technologies at the "Drug Delivery 2007 Conference" in San Francisco on April 10, 2007
April 03, 2007 17:57 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA -- (MARKET WIRE) -- April 3, 2007 -- Aegis Therapeutics, a leader in intranasal
drug delivery, will present a talk entitled: "High-Efficiency Delivery of
Peptides, Proteins, and Other...
Aegis Therapeutics to Present at the "2nd Modern Drug Discovery & Development Summit" in Philadelphia in December 2006
November 16, 2006 09:00 ET
|
Aegis Therapeutics
SAN DIEGO, CA -- (MARKET WIRE) -- November 16, 2006 -- Aegis Therapeutics, a leader in intranasal
drug delivery, will present a talk entitled: "High-Efficiency Transmucosal
Delivery of Peptide and...
Aegis' Intravail(R) Technology Provides Effective Oral Delivery of Anti-Sense Drugs in Primates
November 15, 2006 16:13 ET
|
Aegis Therapeutics
SAN DIEGO, CA -- (MARKET WIRE) -- November 15, 2006 -- Aegis Therapeutics, a drug delivery
technology company providing exceptionally high and unmatched
bioavailability for non-invasive intranasal...